Vaxneuvance Drug Interactions

Use with Other Vaccines: Infants and Children Less Than 2 Years of Age: VAXNEUVANCE can be given concomitantly with any of the following vaccine antigens, either as monovalent or combination vaccines: diphtheria, tetanus, pertussis, poliomyelitis (serotypes 1, 2 and 3), hepatitis A, hepatitis B, Haemophilus influenzae type b, measles, mumps, rubella, varicella and rotavirus vaccine [see Clinical Trial Experience under Adverse Reactions and Pharmacology: Pharmacodynamics: Clinical Studies under Actions].
Children and Adolescents 2 Through 17 Years of Age: There are no data on the concomitant administration of VAXNEUVANCE with other vaccines.
Adults: VAXNEUVANCE can be administered concomitantly with inactivated influenza vaccine [see Clinical Trial Experience under Adverse Reactions and Pharmacology: Pharmacodynamics: Clinical Studies under Actions]. There are no data on the concomitant administration of VAXNEUVANCE with other vaccines.
Use with Immunosuppressive Therapies: Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, corticosteroids, therapeutic proteins and targeted immunomodulators may reduce the immune responses to vaccines [see Precautions].